ADC Therapeutics
ADCT
#7499
Rank
NZ$0.70 B
Marketcap
NZ$5.69
Share price
-7.06%
Change (1 day)
74.47%
Change (1 year)

Revenue for ADC Therapeutics (ADCT)

Revenue in 2025 (TTM): NZ$0.12 Billion

According to ADC Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.13 Billion. In 2024 the company made a revenue of NZ$0.12 Billion an increase over the revenue in the year 2023 that were of NZ$0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ADC Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.12 B3.39%
2024 NZ$0.12 B14.2%
2023 NZ$0.10 B-66.73%
2022 NZ$0.33 B565.81%
2021 NZ$49.65 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA